River & Mercantile Asset Management LLP Viking Therapeutics, Inc. Transaction History
River & Mercantile Asset Management LLP
- $511 Million
- Q4 2024
Shares
1 transactions
Others Institutions Holding VKTX
# of Institutions
466Shares Held
65.8MCall Options Held
5.8MPut Options Held
3.76M-
Vanguard Group Inc Valley Forge, PA10.2MShares$244 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$144 Million0.01% of portfolio
-
State Street Corp Boston, MA4.93MShares$118 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.59MShares$62.1 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.16MShares$51.7 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $1.84B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...